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Synthetic Biology of Multicellular Systems: New Platforms and
Applications for Animal Cells and Organisms
Like life itself, synthetic biology began with unicellularorganisms. Early synthetic biologists built genetic circuits
in model prokaryotes and yeast because of their relative
biological simplicity and ease of genetic manipulation. With
superior genetic tools, faster generation times, and better-
understood endogenous gene expression machinery, prokar-
yotes and yeast were (and remain) appealing hosts for the
engineering of synthetic systems. Now in its second decade,
synthetic biology in unicellular organisms has produced myriad
synthetic genetic circuits, a number of industrial applications,
and fundamental new biological insights unlikely to have
emerged from nonsynthetic approaches.
Yet, the biological complexity that made metazoans less
attractive for early synthetic biology is precisely what makes
these organisms exciting targets for a new generation.
Multicellular phenomena such as development (with its linkage
of growth, morphogenesis, and diﬀerentiation) seem dauntingly
complex and have thus far evaded comprehensive under-
standing through biological approaches that rely on perturba-
tions to natural systems. Synthetic approaches based on
bottom-up reconstitution of these phenomena promise
intimate insights, complementary to those obtained through
traditional methods. At the same time, therapeutic applications
of synthetic biology will have to function within, and ideally
exploit, the many complex aspects of multicellular systems. For
all these reasons, synthetic biology of animal cells has become
an exciting, albeit challenging, frontier.
Today, engineering animal cells remains primitive, based on
slow, imprecise, and generally clunky tools. How will we reach
the point where we can routinely design, build, and analyze
synthetic genetic circuits that operate within the inherently
multicellular contexts of developing embryos and mature
tissues? There is some hope: major new advances in DNA
synthesis and assembly enable construction of increasingly
elaborate DNA constructs. New tools for genome targeting,
particularly site-speciﬁc recombinases and programmable
systems such as CRISPRs and TALEs, greatly improve our
control of genome editing.
Yet major technical challenges remain. The predictability and
tunability of synthetic genetic elements remain poor. We often
lack general strategies for isolating synthetic systems from the
host cell and from each other. Locus-speciﬁc eﬀects and clone-
to-clone variation often limit systematic studies that require
comparisons among diﬀerent genotypes. Beyond these
problems of implementation, our molecular toolbox remains
limited. We do not have many regulatable transcription factors
that work well in mammalian cells. We have few orthogonal
signaling components that can link arbitrary intracellular
pathways and enable cells to coordinate with one another in
a controlled fashion; we also lack general and robust methods
for integration of synthetic systems with the natural machinery
of their hosts. At the end of the day, the time it takes to go from
in silico design to stable cell lines containing full circuits, let
alone whole animals, remains painfully long. In short, we need
to better understand the components we do have, grow the
number of components in our toolbox, tackle site-speciﬁc
eﬀects and reduce integration site variability, and speed the
entire process up by an order of magnitude. Such advances will
help us to tackle what is perhaps the biggest problem of all
our lack of understanding of fundamental circuit design
principles. Those principles will emerge only through
construction and rigorous analysis of new synthetic circuits,
enabled by new technologies and an expanding synthetic
biology community.
In this issue, we bring together four papers that bring the
dream of synthetic multicellular biology closer. First, in order to
increase the repertoire of regulatory components available,
Stanton et al. identify homologues of the popular TetR
repressor that target orthogonal binding sites; as with TetR,
variants of these homologues can be deployed as repressors or
activators in vivo. The activity of one such homologue, PhlF,
can be controlled by the small molecule DAPG, analogously to
the control of TetR by doxycycline, thus introducing a much-
needed new inducible system for mammalian synthetic biology.
While new transcription factors are of great utility, coupling
their activity to synthetic or natural environmental cues remains
a major challenge for the ﬁeld. Daringer et al. address this issue
by developing a Modular Extracellular Sensor Architecture
(MESA) that couples programmable detection of extracellular
ligands to the induction of reporter gene expression through
controlled protease recruitment, similarly to the Tango method
previously demonstrated for detecting ligands of G-protein
coupled receptors, receptor tyrosine kinases, and steroid
hormone receptors.1 MESA entails construction of two
synthetic transmembrane fusion proteins with conditionally
dimerizing extracellular sensor domains and an intracellular
domain that is either a protease or a transcription factor with a
linker that contains a protease recognition site; dimerization of
the sensor domains brings the protease in proximity to the
transcription factor domain, which it then cleaves oﬀ of the
fusion protein, releasing it for transit to the nucleus.
Alternatively, the two transmembrane proteins can carry
separate N- and C-terminal domains of the protease, with
dimerization reconstituting protease activity that releases a
transcription factor tethered to a third transmembrane protein.
The MESA system opens up new possibilities for creating
synthetic intercellular signaling circuits in mammalian cells.
A third paper addresses some of the key challenges of
genomic integration of synthetic circuits. We need the ability to
stably integrate constructs into precisely deﬁned sites, subject
to minimal interference from the host genome. Human artiﬁcial
chromosomes (HACs) represent promising vectors for
constructing complex genetic circuits because they are stably
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inherited (similarly to normal chromosomes), can accommo-
date large genetic cargo, minimize undesired interference with
transgenes and endogenous genes, and, once constructed, can
in principle be transferred among cell lines. However, the utility
of HACs in creating transgenic mice is limited by variable
retention rates in mice tissue. Here, Takiguchi et al. report the
development of a mouse artiﬁcial chromosome (MAC)
employing a native mouse centromere and show that this
MAC is stably maintained in a variety of tissues in transgenic
mice. The authors also develop a derivative of the MAC that
contains ﬁve acceptor sites (landing pads) that can be targeted
by corresponding recombinases for site-speciﬁc introduction of
cargo. These MACs promise increased versatility and control,
both in whole animals and in cell culture.
While these three papers represent advances at the cellular
level, the fourth paper tackles synthetic biology at a totally
diﬀerent scaleentire populations of organismsby expand-
ing an elegant synthetic biology approach for controlling insect-
borne disease. The Hay group previously developed a synthetic
self-ish genetic element called Medea that can be used to drive
population replacement in Drosophila by killing non-Medea-
bearing progeny of Medea-bearing mothers.2 Consequently, a
minority of Medea ﬂies is suﬃcient to rapidly spread the
element through a larger wild-type population, enabling them
to potentially spread a disease-inhibiting genetic cargo. The
original Medea worked through microRNA-mediated silencing
of a maternally expressed transcript, myd88, that was required
for zygotic development, coupled with zygotic expression of a
rescue transgene. Akbari et al. now report two novel Medea
systems based on the same principle but targeting diﬀerent
pathways. An expanded Medea toolbox enables new strategies
for mutational stability (i.e., dealing with inactivating mutations
in any one Medea element) and for the controlled elimination
of a given element from the population in case the whole
enterprise goes awry. The authors also use mathematical
modeling to demonstrate how specially designed Medea
constructs could induce population suppression in response
to an environmental cue, such as diapause-inducing drought,
following initial replacement of the population with Medea-
bearing animals. This work will provide a foundation for future
eﬀorts aimed at real-world disease vector control. It is also an
extraordinary example of how a single synthetic biology project
can cut across multiple levels of biological complexity, from a
gene circuit to a developmental process to population
dynamics.
Together, these papers exemplify a few of the remarkably
diverse approaches currently being pursued to realize the many
promises of multicellular synthetic biology. Looking ahead,
there are a mind-boggling number of systems, approaches, and
applications to explore. As we develop the ﬁeld, we need to
pursue new techniques and applications with equal parts
imagination and rigor so that multicellular synthetic biology
realizes it potential as both science and engineeringwhere the
systematic construction of synthetic systems drives new
biological understanding, which in turn advances our synthetic
potential.
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